Form D · Other Health Care

NOVA LEAP HEALTH CORP.

Dartmouth, A5 · CIK 0001742675

Offering snapshot reported Jun 11, 2018 · SEC filing

Reported sold
$123K
Offering amount: $123K
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 31, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 11, 2018Initial$122,536No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-314265
Aggregate offering amount in the US of CAD$158,660.00. US dollar amounts are based on the Bank of Canada rate of exchange reported on May 31, 2018, which was CAD$1.2948 = US$1.00.

Source: Form D, filed Jun 11, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Christopher Dobbin Director, Executive, Promoter
Dana Hatfield Director
Glenn Jessome Executive
Wayne Myles Director
Michael O'keefe Director
Megan Spidle Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
104 37 Wentworth Street
Dartmouth, A5, B2Y 2S9